Trials / Completed
CompletedNCT00869089
Safety and Efficacy of CC-10004 for Prurigo Nodularis
An Open Label, Single Center Study to Assess the Safety and Efficacy of a 24 Week Treatment Course of CC-10004 in Adults With Recalcitrant Nodularis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- University Hospitals Cleveland Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial will include: * Study period up to 7 months. * Office visits monthly lasting approximately 1 hour. * Blood Draws. * Oral medication that is taken 2 times daily. * Photographs and biopsies if agreed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CC-10004 | 30mg,oral medication, BID, for 24 weeks (60mg total DAILY) |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2009-03-25
- Last updated
- 2016-11-02
- Results posted
- 2014-06-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00869089. Inclusion in this directory is not an endorsement.